Task: Answer the multiple-choice question.
Question: Which drug exhibits a -8.982% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a CC(C)OC(=O)Cn1cnc2ccc(Br)cc2c1=O
b CCC(C(=O)NC1CCCC1)N(C(=O)Cn1nnc(-c2cccs2)n1)c1cnc2ccccc2c1
Answer: a. CC(C)OC(=O)Cn1cnc2ccc(Br)cc2c1=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(C)OC(=O)Cn1cnc2ccc(Br)cc2c1=O
CC(C)OC(=O)Cn1cnc2ccc(Br)cc2c1=O
propan-2-yl2-(6-bromo-4-oxoquinazolin-3-yl)acetate